Annual report of the Australian National Poliovirus Reference Laboratory, 2003

Authors

  • Kerri Anne Brussen Victorian Infectious Diseases Reference Laboratory, Locked Bag 815, Carlton South VIC 3053
  • Vicki Stambos Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria
  • Bruce R Thornley Poliovirus Reference Laboratory, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria

DOI:

https://doi.org/10.33321/cdi.2004.28.38

Keywords:

poliovirus, acute flaccid paralysis, surveillance, enterovirus

Abstract

The Australian National Poliovirus Reference Laboratory was established in late 1994, as part of Australia’s commitment to the World Health Organization’s (WHO) polio eradication program. The laboratory continues to play a pivotal role in maintaining Australia's polio-free status through surveillance for cases of acute flaccid paralysis (AFP), the main clinical presentation of poliomyelitis, and the testing of specimens from these cases. The annual notification rate for eligible cases of AFP in Australia for 2003 was 0.83 per 100,000 children less than 15 years of age. The annual non-polio AFP rate after classification of cases by the polio expert committee was 0.68 per 100,000, 32 per cent below WHO’s annual target. While no polioviruses were isolated from the specimens tested from the 27 cases of AFP in 2003, a novel enterovirus (enterovirus 75) was isolated from one case and enterovirus 71 was isolated from another. During the same period 12 polioviruses, referred from cases other than AFP, tested as Sabin-like by the WHO approved methods of intratypic differentiation. The importation of wild polioviruses from endemic Nigeria into surrounding countries of Africa during 2003, highlights the importance of the continuation of AFP surveillance and high quality laboratory activities throughout the world until global eradication of polio is certified. Commun Dis Intell 2004;28:339–344.

Downloads

Download data is not yet available.

References

Kew OM, Pallansch MA. The mechanism of poliovirus eradication. In: Semler BL, Wimmer E, editors. Molecular Biology of Picornaviruses. Washington: ASM Press; 2002. p. 481–491.

Communicable Diseases Network Australia Surveillance Case Definitions Working Group. Editorial: Notifiable diseases, Australia, 2004. Commun Dis Intell 2004;28:1–5

National Health and Medical Research Council. The Australian Immunisation Handbook. 8th edition. Canberra: Australian Government Publishing Service, 2003. p.234–242

Halsey NA, Pinto J, Espinosa-Rosales F, Faure-Fontenla MA, da Silva E, Khan AJ, et al. Search for poliovirus carriers among people with primary immune deficiency disease in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Org 2004;82:3–7.

Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 1998;36:2893–2899.

Martin J, Dunn G, Hull R, Patel V, Minor PD. Evolution of the Sabin strain of type 3 polioviruses in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 2000;74:3001–3010.

Thorley BR, Brussen KA, Stambos V, Yuen LK, Kelly HA. Annual report of the Australian National Poliovirus Reference Laboratory and summary of acute flaccid paralysis surveillance, 2001. Commun Dis Intell 2002;26:419–427.

Thorley BR, Brussen KA, Stambos V, Helly HA. Annual report of the Australian National Poliovirus Reference Laboratory and summary of acute flaccid paralysis surveillance, 2002. Commun Dis Intell 2003;27:352–356.

Whitfield K, Kelly H. Using the two-source capture-recapture method to estimate the incidence of acute flaccid paralysis in Victoria, Australia. Bull World Health Org 2002;80:846–851.

Whitfield K, Kelly H. Notification of patients with acute flaccid paralysis since certification of Australia as polio-free. J Paediatr Child Health (in press).

Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, Pallansch MA. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol 2000;38:1170–1174.

Oberste M, Schnurr D, Maher K, al-Busaidy S, Pallansch M. Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotype. J Gen Virol 2001;82:409–416.

Oberste MS, Michele SM, Maher K, Schnurr D, Cisterna D, Junttila N, et al. Molecular identification of characterization of two proposed new enterovirus serotypes, EV74 and EV75. J Gen Virol. In press 2004.

McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 2001;75:7732–7738.

Herrero LJ, Lee CS, Hurrelbrink RJ, Chua BH, Chua KB, McMinn PC. Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000. Arch Virol 2003;148:1369–1385.

Muir P, Kammerer U, Korn K, Mulders MN, Poyry T, Weissbrich B, et al. Molecular typing of enteroviruses: current status and future requirements. Clin Microbiol Rev 1998;11:202–227.

World Health Organization. Progress towards global eradication of poliomyelitis, 2003 and January–April 2004. Wkly Epidemiol Rec 2004;79:229–234.

Centers for Disease Control and Prevention. Wild poliovirus importations-West and Central Africa, January 2003–March 2004 MMWR Morb Mortal Wkly Rep 2004;53:433–435

Downloads

Published

30/09/04

How to Cite

Brussen, Kerri Anne, Vicki Stambos, and Bruce R Thornley. 2004. “Annual Report of the Australian National Poliovirus Reference Laboratory, 2003”. Communicable Diseases Intelligence 28 (September):339-44. https://doi.org/10.33321/cdi.2004.28.38.